Genpact Ltd (NYSE: G) is -5.07% lower on its value in year-to-date trading and has touched a low of $29.41 and a high of $46.25 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The G stock was last observed hovering at around $32.76 in the last trading session, with the day’s gains setting it 0.19%.
Currently trading at $32.95, the stock is -1.75% and -5.43% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.93 million and changing 0.58% at the moment leaves the stock -7.56% off its SMA200. G registered -27.05% loss for a year compared to 6-month loss of -9.03%. The firm has a 50-day simple moving average (SMA 50) of $1.53 and a 200-day simple moving average (SMA200) of $8.88.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -5.34% gain in the last 1 month and extending the period to 3 months gives it a -4.60%, and is 0.86% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.85% over the week and 1.92% over the month.
Genpact Ltd (G) has around 129100 employees, a market worth around $5.96B and $4.48B in sales. Current P/E ratio is 9.64 and Fwd P/E is 9.99. Profit margin for the company is 14.10%. Distance from 52-week low is 12.04% and -28.76% from its 52-week high. The company has generated returns on investments over the last 12 months (19.44%).
Genpact Ltd quarterly earnings per share for the current quarter are estimated at $0.68 with sales reaching $1.11B over the same period.The EPS is expected to grow by 1.06% this year, but quarterly earnings will post 2.70% year-over-year. Quarterly sales are estimated to grow 1.10% in year-over-year returns.
Genpact Ltd (G) Top Institutional Holders
495 institutions hold shares in Genpact Ltd (G), with institutional investors hold 99.92% of the company’s shares. The shares outstanding are 179.49M, and float is at 178.74M with Short Float at 1.89%. Institutions hold 98.92% of the Float.
The top institutional shareholder in the company is Blackrock Inc. with over 19.36 million shares valued at $727.19 million. The investor’s holdings represent 10.67% of the G Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 16.75 million shares valued at $629.19 million to account for 9.24% of the shares outstanding. The other top investors are FMR, LLC which holds 16.32 million shares representing 9.00% and valued at over $613.04 million, while Wellington Management Group, LLP holds 7.77% of the shares totaling 14.08 million with a market value of $528.96 million.
Genpact Ltd (G) Insider Activity
The most recent transaction is an insider sale by Klunk Donald J,the company’sChief Accounting Officer. SEC filings show that Klunk Donald J sold 1,845 shares of the company’s common stock on Feb 15 ’24 at a price of $36.27 per share for a total of $66910.0. Following the sale, the insider now owns 6922.0 shares.
Genpact Ltd disclosed in a document filed with the SEC on Jan 22 ’24 that White Heather (SVP & Chief Legal Officer) sold a total of 11,450 shares of the company’s common stock. The trade occurred on Jan 22 ’24 and was made at $36.00 per share for $0.41 million. Following the transaction, the insider now directly holds 21175.0 shares of the G stock.
Still, SEC filings show that on Dec 04 ’23, Stein Kathryn Vanpelt (Senior Vice President) disposed off 57,336 shares at an average price of $34.85 for $2.0 million. The insider now directly holds 85,775 shares of Genpact Ltd (G).
